SLC12A9 Inhibitors are a specialized category of chemical agents that target the SLC12A9 protein, known for its inhibitory effects on SLC12A1 and its role as a possible subunit in multimeric transport systems. These inhibitors operate by directly binding to specific domains of SLC12A9, neutralizing its ability to inhibit SLC12A1 or to act as a functional subunit in a larger complex. For example, some compounds in this class may target the protein's inhibitory domains, essentially switching off its capacity to counteract the activity of SLC12A1. Others might focus on the domains responsible for forming multimeric complexes, thereby disrupting SLC12A9's role in these systems.
While the specificity of these inhibitors can vary, the primary objective is to interfere with SLC12A9's known or presumed functions. They are generally small molecules capable of crossing cellular membranes to reach the cytosolic domain where SLC12A9 operates. Once there, they bind to the protein and disrupt its function, either by preventing it from inhibiting SLC12A1 or by blocking its participation in multimeric transport systems. However, it's worth noting that the degree to which these inhibitors affect only SLC12A9, as opposed to other cellular functions, is subject to further research and confirmation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide could directly interfere with SLC12A9's ability to inhibit SLC12A1 by binding to similar regulatory sites. | ||||||
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | $109.00 $228.00 | 9 | |
Bumetanide (Ro 10-6338) may target SLC12A9's active site, affecting its potential inhibitory role toward SLC12A1. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
This compound could bind to SLC12A9 and affect its ability to interact with other subunits, compromising its function in the multimeric transport system. | ||||||
Torsemide | 56211-40-6 | sc-213059 | 10 mg | $260.00 | ||
Torsemide might selectively target SLC12A9's interaction domains, disrupting its capacity to inhibit SLC12A1. | ||||||
Ethacrynic acid | 58-54-8 | sc-257424 sc-257424A | 1 g 5 g | $90.00 $300.00 | 5 | |
Ethacrynic Acid could directly block SLC12A9's binding sites for the multimeric complex, affecting its functional role as a subunit. | ||||||
Indapamide | 26807-65-8 | sc-204777 sc-204777A | 250 mg 1 g | $46.00 $64.00 | ||
Indapamide may interfere with SLC12A9's ability to form functional multimeric complexes, thereby inhibiting its activity. | ||||||
Metolazone | 17560-51-9 | sc-211900 | 100 mg | $228.00 | ||
Metolazone could disrupt SLC12A9's interaction with other complex subunits, impeding its role within the multimeric transport system. | ||||||
Chlorthalidone | 77-36-1 | sc-207427 | 25 mg | $243.00 | 1 | |
Chlorthalidone might target SLC12A9's inhibitory domain, affecting its role as an inhibitor of SLC12A1. | ||||||
Xipamide | 14293-44-8 | sc-391196 | 100 mg | $302.00 | ||
Xipamide could inhibit SLC12A9 by targeting its functional domains, affecting its role as a subunit in the multimeric transport system. | ||||||